EP
TWST icon

Essential Partners’s Twist Bioscience TWST Stock Holding History

Essential Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.1K Hold
273
– – 0.01% 784
2026
Q1 		$13K Buy
273
+20
+8% +$897 ﹤0.01% 1122
2025
Q4 		$8.03K Buy
253
+8
+3% +$250 ﹤0.01% 1249
2025
Q3 		$6.89K Buy
245
+106
+76% +$3.21K ﹤0.01% 1296
2025
Q2 		$5.11K Buy
+139
New +$4.8K ﹤0.01% 1046

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Essential Partners's TWST Position: Q2 2026 in Review

Essential Partners held its Twist Bioscience (TWST) position steady in Q2 2026 at 273 shares worth $28.1K. The position accounts for 0.01% of the portfolio, ranked #784.

Essential Partners first reported a position in TWST in Q2 2025 and has held it in 5 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Essential Partners held 273 shares of Twist Bioscience worth $28.1K as of Q2 2026.
  • Essential Partners left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up 0.01% of Essential Partners's portfolio in Q2 2026, its #784 holding.
  • Essential Partners first reported a position in Twist Bioscience in Q2 2025 and has held it in 5 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.